Tyra Biosciences, Inc.

NasdaqGS:TYRA Stock Report

Market Cap: US$973.3m

Tyra Biosciences Management

Management criteria checks 2/4

Tyra Biosciences' CEO is Todd Harris, appointed in Nov 2018, has a tenure of 5.5 years. total yearly compensation is $4.63M, comprised of 13.2% salary and 86.8% bonuses, including company stock and options. directly owns 2.86% of the company’s shares, worth $27.88M. The average tenure of the management team and the board of directors is 3.3 years and 4.3 years respectively.

Key information

Todd Harris

Chief executive officer

US$4.6m

Total compensation

CEO salary percentage13.2%
CEO tenure5.5yrs
CEO ownership2.9%
Management average tenure3.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate

Jan 13
We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate

We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth

Sep 27
We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Jun 13
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Feb 23
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Nov 09
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences GAAP EPS of -$0.36

Aug 04

Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Jul 21
Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Mar 31
Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth

Dec 15
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Todd Harris's remuneration changed compared to Tyra Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$5mUS$608k

-US$69m

Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$51m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$2mUS$581k

-US$55m

Sep 30 2022n/an/a

-US$52m

Jun 30 2022n/an/a

-US$46m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$6mUS$443k

-US$26m

Sep 30 2021n/an/a

-US$20m

Jun 30 2021n/an/a

-US$16m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$1mUS$350k

-US$9m

Compensation vs Market: Todd's total compensation ($USD4.63M) is above average for companies of similar size in the US market ($USD3.45M).

Compensation vs Earnings: Todd's compensation has increased whilst the company is unprofitable.


CEO

Todd Harris (44 yo)

5.5yrs

Tenure

US$4,626,119

Compensation

Dr. Todd Harris, Ph D., co-founded Tyra Biosciences, Inc. and also has been its President, Chief Executive Officer and Secretary since November, 2018, Treasurer since February 2019 and Director since Augus...


Leadership Team

NamePositionTenureCompensationOwnership
Todd Harris
Co-Founder5.5yrsUS$4.63m2.86%
$ 27.9m
Alan Fuhrman
Chief Financial Officer1.3yrsUS$3.53m0.0046%
$ 44.4k
Hiroomi Tada
Chief Medical Officer3.5yrsUS$2.41m0.16%
$ 1.6m
Daniel Bensen
Co-Founder & COO5.5yrsUS$2.43m0.82%
$ 8.0m
Robert Hudkins
Chief Technology Officer3.3yrsno data0.52%
$ 5.1m
Ronald Swanson
Chief Scientific Officer4.3yrsUS$2.53mno data
Ali Fawaz
General Counsel2yrsUS$2.76m0.0032%
$ 31.4k
Sarah Honig
Vice President of Corporate Development & Strategy1.8yrsno datano data
Piyush Patel
Chief Development Officer3.3yrsno data0.14%
$ 1.4m
Amy Conrad
Investor Contactno datano datano data

3.3yrs

Average Tenure

59yo

Average Age

Experienced Management: TYRA's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Todd Harris
Co-Founder5.8yrsUS$4.63m2.86%
$ 27.9m
Robert J. More
Independent Director5.5yrsUS$231.55k0%
$ 0
Peter Smith
Scientific Advisorno datano datano data
Gilla Kaplan
Independent Director5.2yrsUS$195.05k0.054%
$ 523.1k
Nina Kjellson
Independent Director4.3yrsUS$196.05k0%
$ 0
Brian Schwartz
Scientific Advisorno datano datano data
William Hahn
Scientific Advisorno datano datano data
Isan Chen
Independent Director5.3yrsUS$191.05k0.37%
$ 3.6m
Rehan Verjee
Independent Director2.9yrsUS$201.05k0%
$ 0
Siddarth Subramony
Independent Director4.3yrsUS$191.05k0%
$ 0
Melissa McCracken
Independent Director3.2yrsno datano data
Jake Simson
Independent Director4.3yrsUS$200.05k0%
$ 0

4.3yrs

Average Tenure

46yo

Average Age

Experienced Board: TYRA's board of directors are considered experienced (4.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.